Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Ocular Therapeutix, Inc

NASDAQ: OCUL · Life Sciences · 8 alerts · CIK 1393434

Share price
$6.01Close, Nov 16
Market cap
$1.32B
Shares outstanding
220.02MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ocular Therapeutix, Inc filings on SEC EDGAR ↗

7:28 AM ET 8-K
Leadership Change

Ocular Therapeutix Leadership Change

Ocular Therapeutix appointed Riad Sherif, M.D., to its Board of Directors as a Class I member, effective November 6, 2026. Dr. Sherif, currently the CEO of Oculis Holding AG and a former Alcon executive, received an initial equity grant of 88,000 stock options and 28,000 restricted stock units as part of his appointment.

Counterparty
Riad Sherif, M.D.
4:15 PM ET 8-K
Leadership Change

Ocular Therapeutix Leadership Change

Sanjay Nayak, M.B.B.S., Ph.D., notified Ocular Therapeutix of his resignation as Chief Strategy Officer, effective October 16, 2026. Dr. Nayak is leaving the company to become the Chief Executive Officer of a privately-held company.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.